BIOPHARMA AND BEYOND: GBI LAUNCHES DEVINT FOR MED DEVICE INTELLIGENCE

Building on years of experience in healthcare intelligence, GBI has launched DEVINT, an online information system covering the medical device and diagnostics landscape in China. DEVINT leverages GBI’s unique automated and manual data collection techniques, equipping users with the information and tools they need to aggressively seize opportunities in China’s rapidly growing medical device industry.

DEVINT tracks products, companies, pipeline applications, pipeline supplemental materials, tendering, medical services and more to give device manufacturers the market transparency necessary to develop successful strategies that translate into measureable value and actionable results. Additionally, every DEVINT subscription comes with access to exclusive device news briefs covering major product approvals, breaking policy announcements and industry mergers and acquisitions.